Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionISCG - iShares Morningstar Small-Cap Growth ETF
Latest Disclosed Ownership18,524 shares
Latest Disclosed Value $ 521,080
ISCG - iShares Morningstar Small-Cap Growth ETF reports 4.71% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On June 26, 2026 - ISCG - iShares Morningstar Small-Cap Growth ETF filed a NPORT-P form disclosing ownership of 18,524 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $521,080 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 17,691 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 4.71% during the quarter. The current value of the position is $583,321 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-26 2026-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 18,524 833 4.71 521 21.45 0.0550
2026-03-27 2026-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 17,691 -3,148 -15.11 430 -3.16 0.0491
2025-12-23 2025-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 20,839 444 2.18 443 1.84 0.0571
2025-09-26 2025-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 20,395 3,028 17.44 435 3.33 0.0624
2025-06-26 2025-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 17,367 939 5.72 422 13.78 0.0699
2025-03-26 2025-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 16,428 3,861 30.72 371 35.53 0.0555
2024-12-26 2024-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 12,567 300 2.45 274 29.38 0.0449
2024-09-27 2024-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 12,267 -4,533 -26.98 211 -16.27 0.0358
2024-06-25 2024-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 16,800 91 0.54 253 5.00 0.0476
2024-03-26 2024-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 16,709 6,771 68.13 241 95.12 0.0479
2023-12-26 2023-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 9,938 200 2.05 123 -8.21 0.0346
2023-09-27 2023-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 9,738 -12,966 -57.11 135 -62.88 0.0320
2023-06-26 2023-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 22,704 592 2.68 361 5.56 0.0898
2023-03-28 2023-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 22,112 7,428 50.59 343 68.47 0.0825
2022-12-23 2022-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 14,684 74 0.51 204 36.24 0.0549
2022-09-27 2022-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 14,610 3,352 29.77 150 75.29 0.0402
2022-06-27 2022-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 11,258 -627 -5.28 86 25.00 0.0270
2022-03-29 2022-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 11,885 1,242 11.67 68 9.68 0.0184
2021-12-28 2021-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 10,643 -799 -6.98 63 -6.06 0.0133
2021-09-28 2021-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 11,442 -12,433 -52.08 67 -39.45 0.0136
2021-06-28 2021-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 23,875 23,875 109 0.0143
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.